| 注册
首页|期刊导航|Journal of Biomedical Research|Therapy outcomes of IL-17 and JAK inhibitors in rosacea: A systematic review

Therapy outcomes of IL-17 and JAK inhibitors in rosacea: A systematic review

Xinyi Dai Chenxingyue Zhang Zhiqiang Yin

Journal of Biomedical Research2025,Vol.39Issue(3):P.317-318,2.
Journal of Biomedical Research2025,Vol.39Issue(3):P.317-318,2.DOI:10.7555/JBR.38.20240107

Therapy outcomes of IL-17 and JAK inhibitors in rosacea: A systematic review

Xinyi Dai 1Chenxingyue Zhang 1Zhiqiang Yin1

作者信息

  • 1. Department of Dermatology,the First Affiliated Hospital of Nanjing Medical University,Nanjing,Jiangsu 210029,China
  • 折叠

摘要

关键词

jak inhibitors/target disease more effectively/outcomes/targeted therapies/therapy/phymatous lesions/interleukin/rosacea

分类

医药卫生

引用本文复制引用

Xinyi Dai,Chenxingyue Zhang,Zhiqiang Yin..Therapy outcomes of IL-17 and JAK inhibitors in rosacea: A systematic review[J].Journal of Biomedical Research,2025,39(3):P.317-318,2.

Journal of Biomedical Research

1674-8301

访问量0
|
下载量0
段落导航相关论文